Global and China Hyaluronic Acid for Osteoarthritis Market Insights, Forecast to 2026

Publication ID:

QYR11200866

Publication Date:

November 23, 2020

Pages:

144

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Hyaluronic Acid for Osteoarthritis market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hyaluronic Acid for Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Hyaluronic Acid for Osteoarthritis market is segmented into
Single-Phase
Duplex

Segment by Application, the Hyaluronic Acid for Osteoarthritis market is segmented into
Knee Joint
Hip Joint
Shoulder Joint
Ankle Joint
Others

Regional and Country-level Analysis
The Hyaluronic Acid for Osteoarthritis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hyaluronic Acid for Osteoarthritis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Hyaluronic Acid for Osteoarthritis Market Share Analysis
Hyaluronic Acid for Osteoarthritis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hyaluronic Acid for Osteoarthritis business, the date to enter into the Hyaluronic Acid for Osteoarthritis market, Hyaluronic Acid for Osteoarthritis product introduction, recent developments, etc.
The major vendors covered:
BIOVENTUS
Sanofi
Ferring B.V.
Anika Therapeutics
Fidia Farma
LG Chem
Bohus BioTech
Hangzhou Singclean Medical Products
Biolevox
Vivacy
ideolab
Xediton Pharmaceuticals
Deka
BIOIBERICA

Table Of Contents:

1 Study Coverage
1.1 Hyaluronic Acid for Osteoarthritis Product Introduction
1.2 Market Segments
1.3 Key Hyaluronic Acid for Osteoarthritis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hyaluronic Acid for Osteoarthritis Market Size Growth Rate by Type
1.4.2 Single-Phase
1.4.3 Duplex
1.5 Market by Application
1.5.1 Global Hyaluronic Acid for Osteoarthritis Market Size Growth Rate by Application
1.5.2 Knee Joint
1.5.3 Hip Joint
1.5.4 Shoulder Joint
1.5.5 Ankle Joint
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hyaluronic Acid for Osteoarthritis Market Size, Estimates and Forecasts
2.1.1 Global Hyaluronic Acid for Osteoarthritis Revenue 2015-2026
2.1.2 Global Hyaluronic Acid for Osteoarthritis Sales 2015-2026
2.2 Global Hyaluronic Acid for Osteoarthritis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Hyaluronic Acid for Osteoarthritis Historical Market Size by Region (2015-2020)
2.3.1 Global Hyaluronic Acid for Osteoarthritis Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Hyaluronic Acid for Osteoarthritis Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Hyaluronic Acid for Osteoarthritis Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Hyaluronic Acid for Osteoarthritis Sales Forecast by Region (2021-2026)
2.4.2 Global Hyaluronic Acid for Osteoarthritis Revenue Forecast by Region (2021-2026)

3 Global Hyaluronic Acid for Osteoarthritis Competitor Landscape by Players
3.1 Global Top Hyaluronic Acid for Osteoarthritis Sales by Manufacturers
3.1.1 Global Hyaluronic Acid for Osteoarthritis Sales by Manufacturers (2015-2020)
3.1.2 Global Hyaluronic Acid for Osteoarthritis Sales Market Share by Manufacturers (2015-2020)
3.2 Global Hyaluronic Acid for Osteoarthritis Manufacturers by Revenue
3.2.1 Global Hyaluronic Acid for Osteoarthritis Revenue by Manufacturers (2015-2020)
3.2.2 Global Hyaluronic Acid for Osteoarthritis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hyaluronic Acid for Osteoarthritis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hyaluronic Acid for Osteoarthritis Revenue in 2019
3.2.5 Global Hyaluronic Acid for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hyaluronic Acid for Osteoarthritis Price by Manufacturers
3.4 Global Hyaluronic Acid for Osteoarthritis Manufacturing Base Distribution, Product Types
3.4.1 Hyaluronic Acid for Osteoarthritis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hyaluronic Acid for Osteoarthritis Product Type
3.4.3 Date of International Manufacturers Enter into Hyaluronic Acid for Osteoarthritis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hyaluronic Acid for Osteoarthritis Market Size by Type (2015-2020)
4.1.1 Global Hyaluronic Acid for Osteoarthritis Sales by Type (2015-2020)
4.1.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Type (2015-2020)
4.1.3 Hyaluronic Acid for Osteoarthritis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hyaluronic Acid for Osteoarthritis Market Size Forecast by Type (2021-2026)
4.2.1 Global Hyaluronic Acid for Osteoarthritis Sales Forecast by Type (2021-2026)
4.2.2 Global Hyaluronic Acid for Osteoarthritis Revenue Forecast by Type (2021-2026)
4.2.3 Hyaluronic Acid for Osteoarthritis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hyaluronic Acid for Osteoarthritis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Hyaluronic Acid for Osteoarthritis Market Size by Application (2015-2020)
5.1.1 Global Hyaluronic Acid for Osteoarthritis Sales by Application (2015-2020)
5.1.2 Global Hyaluronic Acid for Osteoarthritis Revenue by Application (2015-2020)
5.1.3 Hyaluronic Acid for Osteoarthritis Price by Application (2015-2020)
5.2 Hyaluronic Acid for Osteoarthritis Market Size Forecast by Application (2021-2026)
5.2.1 Global Hyaluronic Acid for Osteoarthritis Sales Forecast by Application (2021-2026)
5.2.2 Global Hyaluronic Acid for Osteoarthritis Revenue Forecast by Application (2021-2026)
5.2.3 Global Hyaluronic Acid for Osteoarthritis Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Hyaluronic Acid for Osteoarthritis Market Size YoY Growth 2015-2026
6.1.1 China Hyaluronic Acid for Osteoarthritis Sales YoY Growth 2015-2026
6.1.2 China Hyaluronic Acid for Osteoarthritis Revenue YoY Growth 2015-2026
6.1.3 China Hyaluronic Acid for Osteoarthritis Market Share in Global Market 2015-2026
6.2 China Hyaluronic Acid for Osteoarthritis Market Size by Players (International and Local Players)
6.2.1 China Top Hyaluronic Acid for Osteoarthritis Players by Sales (2015-2020)
6.2.2 China Top Hyaluronic Acid for Osteoarthritis Players by Revenue (2015-2020)
6.3 China Hyaluronic Acid for Osteoarthritis Historic Market Review by Type (2015-2020)
6.3.1 China Hyaluronic Acid for Osteoarthritis Sales Market Share by Type (2015-2020)
6.3.2 China Hyaluronic Acid for Osteoarthritis Revenue Market Share by Type (2015-2020)
6.3.3 China Hyaluronic Acid for Osteoarthritis Price by Type (2015-2020)
6.4 China Hyaluronic Acid for Osteoarthritis Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Hyaluronic Acid for Osteoarthritis Sales Forecast by Type (2021-2026)
6.4.2 China Hyaluronic Acid for Osteoarthritis Revenue Forecast by Type (2021-2026)
6.4.3 China Hyaluronic Acid for Osteoarthritis Price Forecast by Type (2021-2026)
6.5 China Hyaluronic Acid for Osteoarthritis Historic Market Review by Application (2015-2020)
6.5.1 China Hyaluronic Acid for Osteoarthritis Sales Market Share by Application (2015-2020)
6.5.2 China Hyaluronic Acid for Osteoarthritis Revenue Market Share by Application (2015-2020)
6.5.3 China Hyaluronic Acid for Osteoarthritis Price by Application (2015-2020)
6.6 China Hyaluronic Acid for Osteoarthritis Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Hyaluronic Acid for Osteoarthritis Sales Forecast by Application (2021-2026)
6.6.2 China Hyaluronic Acid for Osteoarthritis Revenue Forecast by Application (2021-2026)
6.6.3 China Hyaluronic Acid for Osteoarthritis Price Forecast by Application (2021-2026)

7 North America
7.1 North America Hyaluronic Acid for Osteoarthritis Market Size YoY Growth 2015-2026
7.2 North America Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
7.2.1 North America Hyaluronic Acid for Osteoarthritis Sales by Country (2015-2020)
7.2.2 North America Hyaluronic Acid for Osteoarthritis Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Hyaluronic Acid for Osteoarthritis Market Size YoY Growth 2015-2026
8.2 Europe Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
8.2.1 Europe Hyaluronic Acid for Osteoarthritis Sales by Country
8.2.2 Europe Hyaluronic Acid for Osteoarthritis Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Hyaluronic Acid for Osteoarthritis Market Size YoY Growth 2015-2026
9.2 Asia Pacific Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
9.2.1 Asia Pacific Hyaluronic Acid for Osteoarthritis Sales by Region (2015-2020)
9.2.2 Asia Pacific Hyaluronic Acid for Osteoarthritis Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Hyaluronic Acid for Osteoarthritis Market Size YoY Growth 2015-2026
10.2 Latin America Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
10.2.1 Latin America Hyaluronic Acid for Osteoarthritis Sales by Country
10.2.2 Latin America Hyaluronic Acid for Osteoarthritis Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Hyaluronic Acid for Osteoarthritis Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Hyaluronic Acid for Osteoarthritis Market Facts & Figures by Country
11.2.1 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales by Country
11.2.2 Middle East and Africa Hyaluronic Acid for Osteoarthritis Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 BIOVENTUS
12.1.1 BIOVENTUS Corporation Information
12.1.2 BIOVENTUS Description and Business Overview
12.1.3 BIOVENTUS Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BIOVENTUS Hyaluronic Acid for Osteoarthritis Products Offered
12.1.5 BIOVENTUS Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Hyaluronic Acid for Osteoarthritis Products Offered
12.2.5 Sanofi Recent Development
12.3 Ferring B.V.
12.3.1 Ferring B.V. Corporation Information
12.3.2 Ferring B.V. Description and Business Overview
12.3.3 Ferring B.V. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Ferring B.V. Hyaluronic Acid for Osteoarthritis Products Offered
12.3.5 Ferring B.V. Recent Development
12.4 Anika Therapeutics
12.4.1 Anika Therapeutics Corporation Information
12.4.2 Anika Therapeutics Description and Business Overview
12.4.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Products Offered
12.4.5 Anika Therapeutics Recent Development
12.5 Fidia Farma
12.5.1 Fidia Farma Corporation Information
12.5.2 Fidia Farma Description and Business Overview
12.5.3 Fidia Farma Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Fidia Farma Hyaluronic Acid for Osteoarthritis Products Offered
12.5.5 Fidia Farma Recent Development
12.6 LG Chem
12.6.1 LG Chem Corporation Information
12.6.2 LG Chem Description and Business Overview
12.6.3 LG Chem Sales, Revenue and Gross Margin (2015-2020)
12.6.4 LG Chem Hyaluronic Acid for Osteoarthritis Products Offered
12.6.5 LG Chem Recent Development
12.7 Bohus BioTech
12.7.1 Bohus BioTech Corporation Information
12.7.2 Bohus BioTech Description and Business Overview
12.7.3 Bohus BioTech Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bohus BioTech Hyaluronic Acid for Osteoarthritis Products Offered
12.7.5 Bohus BioTech Recent Development
12.8 Hangzhou Singclean Medical Products
12.8.1 Hangzhou Singclean Medical Products Corporation Information
12.8.2 Hangzhou Singclean Medical Products Description and Business Overview
12.8.3 Hangzhou Singclean Medical Products Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Products Offered
12.8.5 Hangzhou Singclean Medical Products Recent Development
12.9 Biolevox
12.9.1 Biolevox Corporation Information
12.9.2 Biolevox Description and Business Overview
12.9.3 Biolevox Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biolevox Hyaluronic Acid for Osteoarthritis Products Offered
12.9.5 Biolevox Recent Development
12.10 Vivacy
12.10.1 Vivacy Corporation Information
12.10.2 Vivacy Description and Business Overview
12.10.3 Vivacy Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vivacy Hyaluronic Acid for Osteoarthritis Products Offered
12.10.5 Vivacy Recent Development
12.11 BIOVENTUS
12.11.1 BIOVENTUS Corporation Information
12.11.2 BIOVENTUS Description and Business Overview
12.11.3 BIOVENTUS Sales, Revenue and Gross Margin (2015-2020)
12.11.4 BIOVENTUS Hyaluronic Acid for Osteoarthritis Products Offered
12.11.5 BIOVENTUS Recent Development
12.12 Xediton Pharmaceuticals
12.12.1 Xediton Pharmaceuticals Corporation Information
12.12.2 Xediton Pharmaceuticals Description and Business Overview
12.12.3 Xediton Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Xediton Pharmaceuticals Products Offered
12.12.5 Xediton Pharmaceuticals Recent Development
12.13 Deka
12.13.1 Deka Corporation Information
12.13.2 Deka Description and Business Overview
12.13.3 Deka Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Deka Products Offered
12.13.5 Deka Recent Development
12.14 BIOIBERICA
12.14.1 BIOIBERICA Corporation Information
12.14.2 BIOIBERICA Description and Business Overview
12.14.3 BIOIBERICA Sales, Revenue and Gross Margin (2015-2020)
12.14.4 BIOIBERICA Products Offered
12.14.5 BIOIBERICA Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hyaluronic Acid for Osteoarthritis Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hyaluronic Acid for Osteoarthritis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

BIOVENTUS
Sanofi
Ferring B.V.
Anika Therapeutics
Fidia Farma
LG Chem
Bohus BioTech
Hangzhou Singclean Medical Products
Biolevox
Vivacy
ideolab
Xediton Pharmaceuticals
Deka
BIOIBERICA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.